Geode Capital Management, LLC Terns Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,207,479 shares of TERN stock, worth $7.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,207,479

Previous 1,121,862 7.63%

Holding current value

$7.88 Million

Previous $7.64 Million 31.82%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.49 - $10.8 $555,654 - $924,663	85,617 Added 7.63%	1,207,479 $10.1 Million
Q2 2024 Aug 09, 2024	BUY	$4.54 - $8.2 $1.16 Million - $2.1 Million	255,941 Added 29.56%	1,121,862 $7.64 Million
Q1 2024 May 13, 2024	BUY	$4.86 - $8.19 $123,745 - $208,533	25,462 Added 3.03%	865,921 $5.68 Million
Q4 2023 Feb 13, 2024	BUY	$3.37 - $6.86 $176,399 - $359,079	52,344 Added 6.64%	840,459 $5.45 Million
Q3 2023 Nov 13, 2023	BUY	$4.7 - $8.55 $2,838 - $5,164	604 Added 0.08%	788,115 $3.96 Million
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.29 $3.55 Million - $6.42 Million	482,795 Added 158.44%	787,511 $6.89 Million
Q1 2023 May 15, 2023	BUY	$7.91 - $12.0 $1.01 Million - $1.52 Million	127,068 Added 71.53%	304,716 $3.61 Million
Q4 2022 Feb 13, 2023	BUY	$4.62 - $10.18 $40,656 - $89,584	8,800 Added 5.21%	177,648 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$1.87 - $6.42 $167,409 - $574,744	89,524 Added 112.86%	168,848 $994,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.0 $149,980 - $299,961	-99,987 Reduced 55.76%	79,324 $196,000
Q1 2022 May 13, 2022	SELL	$2.83 - $6.7 $4,595 - $10,880	-1,624 Reduced 0.9%	179,311 $532,000
Q4 2021 Feb 11, 2022	SELL	$5.65 - $10.73 $70,065 - $133,062	-12,401 Reduced 6.41%	180,935 $1.28 Million
Q3 2021 Nov 12, 2021	BUY	$7.22 - $13.46 $362,927 - $676,593	50,267 Added 35.13%	193,336 $2.01 Million
Q2 2021 Aug 13, 2021	BUY	$12.26 - $22.0 $157,001 - $281,732	12,806 Added 9.83%	143,069 $1.75 Million
Q1 2021 May 12, 2021	BUY	$17.13 - $27.25 $2.23 Million - $3.55 Million	130,263 New	130,263 $2.87 Million

Others Institutions Holding TERN

# of Institutions

167

Shares Held

78.3M

Call Options Held

580K

Put Options Held

454K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $246M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Terns Pharmaceuticals, Inc. Transaction History